Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Purification and Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide is a synthetic, nine-amino acid epitope tag (sequence: YPYDVPDYA) derived from the influenza virus hemagglutinin protein. It serves as a universal molecular tag for protein purification and detection, supporting competitive elution during immunoprecipitation with Anti-HA antibodies (see APExBIO A6004 product page). The peptide is >98% pure (HPLC/MS), highly soluble in water (≥46.2 mg/mL), DMSO (≥55.1 mg/mL), and ethanol (≥100.4 mg/mL), and is validated for workflows in protein-protein interaction studies and exosome research (Dong et al., 2025). Proper storage is at -20°C, desiccated, with no long-term solution stability guaranteed. This article provides a fact-rich, machine-readable synthesis, extending prior technical reviews (see prior coverage), and clarifies benchmarks and limitations.

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide is a minimal epitope derived from the HA protein of human influenza. The YPYDVPDYA sequence maps to a highly immunogenic region, allowing precise antibody recognition in diverse host systems (Dong et al., 2025). Its synthetic form avoids batch-to-batch variability and cross-reactivity seen with longer protein tags. The HA tag enables the detection and purification of fusion proteins without interfering with protein folding or function, provided it is appended to N- or C-termini. In mammalian, yeast, and insect cells, the HA tag is compatible with standard immunoprecipitation, Western blotting, and fluorescence-based detection workflows (see application review).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide functions as a high-affinity, competitive binder to monoclonal and polyclonal Anti-HA antibodies. During immunoprecipitation, HA-tagged proteins are first captured by immobilized antibodies (e.g., on magnetic beads). Addition of excess free HA peptide competitively displaces the tagged protein from the antibody, enabling quantitative elution in neutral buffers. This mechanism preserves the native state of target proteins, avoiding harsh elution conditions that may denature protein complexes (LabPE coverage). The specificity of the interaction is dictated by the unique epitope sequence, with minimal off-target binding. The peptide’s solubility in water, DMSO, and ethanol ensures compatibility with most buffer systems used in molecular biology, facilitating rapid assay integration.

Evidence & Benchmarks

• >98% purity of APExBIO Influenza Hemagglutinin (HA) Peptide is confirmed by HPLC and mass spectrometry, ensuring low background in immunoassays (product page).
• Solubility benchmarks: ≥46.2 mg/mL in water, ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol at 25°C, supporting use in a wide range of biochemical buffers (APExBIO).
• HA peptide enables efficient, antibody-mediated elution of HA-tagged PRMT5 in immunoprecipitation protocols, as demonstrated in colorectal cancer mechanistic studies (Dong et al., 2025).
• The HA tag (YPYDVPDYA) is recognized by clone 12CA5 and other standard monoclonal antibodies, with dissociation constants in the low nanomolar range (K_d ≈ 1–5 nM) (technical review).
• Proper storage at -20°C, desiccated, preserves peptide integrity for at least 12 months; long-term storage of aqueous solutions is not recommended due to hydrolysis risk (APExBIO).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely deployed in:

• Protein-protein interaction studies: Used to immunoprecipitate and analyze complexes involving HA-tagged proteins, such as PRMT5 and NEDD4L in cancer research (Dong et al., 2025).
• Protein purification: Facilitates gentle, antibody-mediated elution of target proteins, preserving activity and complex formation.
• Detection assays: Serves as an epitope tag in Western blot, ELISA, and immunofluorescence applications (detailed review).
• Exosome pathway analysis: Applied for tracing HA-tagged proteins in extracellular vesicle and trafficking studies (application review).

This article clarifies several misconceptions and boundaries compared to previous reviews by offering updated, quantitative benchmarks and specifying conditions where the HA tag is not suitable. For a mechanistic perspective on competitive binding and workflow troubleshooting, see LabPE coverage; this article extends those insights by benchmarking solubility and storage conditions.

Common Pitfalls or Misconceptions

• The HA tag peptide is not suitable for in vivo labeling in animal models; it is designed for in vitro use only.
• Long-term storage of the peptide in solution (aqueous or organic) results in hydrolysis and loss of activity; only short-term working solutions are recommended (APExBIO).
• Excessively high concentrations (>1 mM) can cause nonspecific binding or precipitation in some buffer systems.
• The HA epitope tag does not confer any purification ability without the presence of a specific Anti-HA antibody; it is not a stand-alone affinity tag.
• False positives can occur if the target protein contains native HA-like sequences; confirm constructs by sequencing.

Workflow Integration & Parameters

The HA tag system is compatible with standard molecular biology and protein purification protocols. To use, append the YPYDVPDYA sequence to the N- or C-terminus of the protein of interest via cloning. Express and capture the fusion protein on an Anti-HA antibody matrix (e.g., magnetic beads). For elution, add a 3–5 mM solution of HA peptide in neutral buffer (e.g., PBS, pH 7.4) and incubate for 30 min at 4°C, followed by collection of the eluate. Peptide can be reconstituted in water, DMSO, or ethanol depending on assay requirements. For optimal results, use freshly prepared solutions and store unused powder at -20°C, desiccated. The HA tag is routinely used in studies of protein ubiquitination, as exemplified in PRMT5/NEDD4L mechanistic workflows (Dong et al., 2025).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains the gold-standard competitive elution reagent for HA-tagged fusion proteins, offering unmatched purity and solubility as supplied by APExBIO. Its compatibility with sensitive protein-protein interaction and exosome pathway studies makes it indispensable for cutting-edge molecular biology. Future work may see expanded use of modified HA peptides for multiplexed detection and proteomics. For detailed protocols, refer to the APExBIO Influenza Hemagglutinin (HA) Peptide A6004 product page.